Sector: Healthcare
Location:
Cambridge, MA
Year Funded:
1998
Status:
IPO/Acquired by Millennium Pharmaceuticals
|
|
 Summary:
LeukoSite developed drugs to block disease promoting actions of white blood cells, with potential applications within the areas of cancer, autoimmune and viral diseases.
|
|